Photothermal therapy
Photothermal therapy (PTT) is a minimally invasive cancer treatment modality that leverages light-absorbing agents to generate localized heat for tumor ablation.
Photothermal therapy (PTT) is a minimally invasive cancer treatment modality that leverages light-absorbing agents to generate localized heat for tumor ablation. The mechanism relies on converting absorbed photons—typically in the near-infrared (NIR) spectrum for optimal tissue penetration—into thermal energy, which induces cellular damage, apoptotic process activation, and tumor cell death. PTT offers several advantages over conventional approaches: spatial selectivity allows targeting of tumors while sparing surrounding tissue, reduced systemic toxicity compared to chemotherapy, and compatibility with multimodal theranostic platforms that combine therapy with real-time imaging and monitoring. The field has rapidly expanded through development of various nanoparticulate photothermal agents, including plasmonic metals (gold nanoparticles and nanorods), metal sulfides (Cu₂S), metal oxides (TiO₂), and carbon-based nanomaterials, each offering tunable optical properties and surface chemistry for enhanced biocompatibility and tumor targeting.
Where the papers sit
17 papers from the last 6 months study photothermal therapy directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 human data · 16 preclinical
Themes one subject · 1 paradigm shift
Those 17 are all about one subject.
-
Multimodal Nanomedicine
Stimulus-responsive nanoplatforms are being used to pair localized heating with chemotherapy, radiotherapy, ferroptosis, cuproptosis, immunotherapy and antibacterial action. Tumor studies emphasize targeted delivery, reversal of chemoresistance and systemic antitumor immunity, while wound studies target biofilms, inflammation and diabetic healing. Gold, silica, polydopamine and metal-based materials recur as multifunctional therapeutic cores. The shared direction is integrated treatment and biosafety optimization, although efficacy remains largely preclinical.
Mild photothermal therapy can eradicate difficult infections when paired with pathogen-sensitizing or catalytic mechanisms
The MoS2/ZnO hydrogel for S. aureus-infected diabetic wounds 42775574Sep, the glucose-responsive gold-nanocluster hydrogel for biofilm-infected diabetic wounds 42611790Aug, and the hesperidin/Fe3+ nanoplatform for biofilm-associated skin abscesses 42468758Jul each challenge the assumption that effective bacterial ablation requires high-temperature photothermal treatment because mild heating is defeated by bacterial heat-shock defenses. Instead, these systems achieved antibacterial or antibiofilm activity under mild photothermal conditions by sensitizing bacteria with Zn2+, generating hydroxyl radicals catalytically in the wound environment, or suppressing DnaK/HSP70-associated heat tolerance while adding chemodynamic and anti-biofilm effects. The resulting direction is to treat mild photothermal heating as an enabling component of coordinated antimicrobial mechanisms rather than as the sole agent responsible for thermal killing, potentially separating efficacy from collateral tissue damage.
Papers
The 17 papers from the last 6 months that study photothermal therapy directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Multimodal Nanomedicine (17)
- Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition. Molecular pharmaceutics · 2 Nov 2026 PMID 42969708
- Integrated Droplet Microfluidic Platform for Single-Spheroid Photothermal Nanotherapy and Morphology-Driven Response Prediction. ACS applied materials & interfaces · 23 Oct 2026 PMID 42912452
- Dual-Responsive Nanoplatform: In Situ Self-Assembly Enables OFF-to-ON Photothermal Switching for Multimodal Synergistic Tumor Therapy. ACS applied materials & interfaces · 19 Oct 2026 PMID 42895892
- Design of silica-core gold-shell nanoparticles for photothermal breast tumor therapy: a two-arm comparison of surface cooling with nanoparticle self-attenuation. Biomedical physics & engineering express · 14 Oct 2026 PMID 42874630
- Orchestrating diabetic wound healing via MoS2 and Zn2+ integrated poly(vinyl alcohol)/dextran hydrogels: decoupling the efficacy-biosafety paradox in mild photothermal therapy. Journal of materials chemistry. B · 23 Sept 2026 PMID 42775574
- Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer. International journal of oncology · 21 Aug 2026 PMID 42627061
- A glucose-triggered cascade catalytic adhesive hydrogel enables mild photothermal-biofilm eradication for infected diabetic wounds. Journal of materials chemistry. B · 18 Aug 2026 PMID 42611790
- A dual-responsive nanosystem for synergistic antibacterial therapy and inflammatory microenvironment modulation in infected diabetic wound healing. Biomaterials science · 11 Aug 2026 PMID 42578380
- A hesperidin-engineered metal-phenolic nanoplatform for biofilm-targeted and self-amplified photothermal/chemodynamic therapy of skin abscesses. Journal of controlled release : official journal of the Controlled Release Society · 17 Jul 2026 PMID 42468758
- Machine learning-optimized charge transfer nanocrystals for synergistic NIR photothermal therapy, ferroptosis, and electrochemical detection of breast cancer. Colloids and surfaces. B, Biointerfaces · 10 Jul 2026 PMID 42431118
- Localized gold nanoparticles-mediated photothermal therapy for head and neck cancer: in vivo proof-of-concept. International journal of pharmaceutics · 4 Jul 2026 PMID 42401299
- A Carbon Quantum Dot-Derived Platform Combining Photothermal and 131I Radionuclide Oncotherapy. ACS applied bio materials · 27 Jun 2026 PMID 42363901
- Dual-quenched and redox-responsive gold nanoplatforms for tumor-specific multimodal theranostics. Nanoscale · 26 Jun 2026 PMID 42358224
- Fe3+-responsive aggregable gold nanoplatform enables siRNA-mediated chemoresistance reversal and combined photothermal-temozolomide therapy for glioblastoma. Acta biomaterialia · 18 Jun 2026 PMID 42315000
- Asymmetric polydopamine-coated polyacrylic acid-ammonia borane nanoparticles as a hydrogen storage material for synergistic hydrogen and photothermal therapy. Journal of colloid and interface science · 6 Jun 2026 PMID 42250311
- Hyaluronic acid-camouflaged dendritic silica nanoparticles enable targeted cuproptosis and photothermal therapy for lung cancer. Colloids and surfaces. B, Biointerfaces · 5 Jun 2026 PMID 42247956
- Dual-functional chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted Bcl-2 siRNA delivery and photothermal therapy in bladder cancer. Journal of biotechnology · 20 May 2026 PMID 42162746
By study type
Human data, design not indexed (1)
- Design of silica-core gold-shell nanoparticles for photothermal breast tumor therapy: a two-arm comparison of surface cooling with nanoparticle self-attenuation. Biomedical physics & engineering express · 14 Oct 2026 PMID 42874630
Preclinical: animal, cell and lab studies (16)
- Glutathione-Responsive Nano-Prodrug Mediates Synergistic Photothermal Chemotherapy for Tumor Inhibition. Molecular pharmaceutics · 2 Nov 2026 PMID 42969708
- Integrated Droplet Microfluidic Platform for Single-Spheroid Photothermal Nanotherapy and Morphology-Driven Response Prediction. ACS applied materials & interfaces · 23 Oct 2026 PMID 42912452
- Dual-Responsive Nanoplatform: In Situ Self-Assembly Enables OFF-to-ON Photothermal Switching for Multimodal Synergistic Tumor Therapy. ACS applied materials & interfaces · 19 Oct 2026 PMID 42895892
- Orchestrating diabetic wound healing via MoS2 and Zn2+ integrated poly(vinyl alcohol)/dextran hydrogels: decoupling the efficacy-biosafety paradox in mild photothermal therapy. Journal of materials chemistry. B · 23 Sept 2026 PMID 42775574
- Single in situ intratumoral low‑dose shikonin hydrogel plus mild photothermal therapy elicits systemic antitumor immunity in immune‑cold triple‑negative breast cancer. International journal of oncology · 21 Aug 2026 PMID 42627061
- A glucose-triggered cascade catalytic adhesive hydrogel enables mild photothermal-biofilm eradication for infected diabetic wounds. Journal of materials chemistry. B · 18 Aug 2026 PMID 42611790
- A dual-responsive nanosystem for synergistic antibacterial therapy and inflammatory microenvironment modulation in infected diabetic wound healing. Biomaterials science · 11 Aug 2026 PMID 42578380
- A hesperidin-engineered metal-phenolic nanoplatform for biofilm-targeted and self-amplified photothermal/chemodynamic therapy of skin abscesses. Journal of controlled release : official journal of the Controlled Release Society · 17 Jul 2026 PMID 42468758
- Machine learning-optimized charge transfer nanocrystals for synergistic NIR photothermal therapy, ferroptosis, and electrochemical detection of breast cancer. Colloids and surfaces. B, Biointerfaces · 10 Jul 2026 PMID 42431118
- Localized gold nanoparticles-mediated photothermal therapy for head and neck cancer: in vivo proof-of-concept. International journal of pharmaceutics · 4 Jul 2026 PMID 42401299
- A Carbon Quantum Dot-Derived Platform Combining Photothermal and 131I Radionuclide Oncotherapy. ACS applied bio materials · 27 Jun 2026 PMID 42363901
- Dual-quenched and redox-responsive gold nanoplatforms for tumor-specific multimodal theranostics. Nanoscale · 26 Jun 2026 PMID 42358224
- Fe3+-responsive aggregable gold nanoplatform enables siRNA-mediated chemoresistance reversal and combined photothermal-temozolomide therapy for glioblastoma. Acta biomaterialia · 18 Jun 2026 PMID 42315000
- Asymmetric polydopamine-coated polyacrylic acid-ammonia borane nanoparticles as a hydrogen storage material for synergistic hydrogen and photothermal therapy. Journal of colloid and interface science · 6 Jun 2026 PMID 42250311
- Hyaluronic acid-camouflaged dendritic silica nanoparticles enable targeted cuproptosis and photothermal therapy for lung cancer. Colloids and surfaces. B, Biointerfaces · 5 Jun 2026 PMID 42247956
- Dual-functional chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted Bcl-2 siRNA delivery and photothermal therapy in bladder cancer. Journal of biotechnology · 20 May 2026 PMID 42162746
Written from 17 PubMed abstracts, each one listed by PMID above. Published: 2026-08-02. Last written: 2026-08-27 by GPT. Drafted by language models from published abstracts; not medical advice.